Inhaled antibiotics in cystic fibrosis: A review

Annals of Pharmacotherapy

Volumn 30, Issue 7-8, 1996, Pages 840-850

  Toso, Cynthia ^a   Williams, Dennis M ^a   Noone, Peader G ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBENICILLIN; CEFALORIDINE; CEFTAZIDIME; CIPROFLOXACIN; CLOXACILLIN; COLISTIN; FLUCLOXACILLIN; GENTAMICIN; TICARCILLIN; TOBRAMYCIN;

AEROSOL; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG THERAPY; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; LUNG INFECTION; NEBULIZATION; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS; REVIEW; SPUTUM ANALYSIS;

EID: 0030015857     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000723     Document Type: Review

References (61)

1. Zach MS. Pathogenesis and management of lung disease in cystic fibrosis. J R Soc Med 1991;84(suppl 18):10-7.
2. Riordan JR, Rommens JM, Kerem BT, Alon N, Rozmahei R. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
3. Kerem BT, Rommens JM, Buchanan JA, Markiewics D, Cox TK. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245: 1073-80.
4. Rommens JM, Iannuzzi MC, Kerem BT, Drumm ML, Melmer G. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
5. Tsui L. The spectrum of cystic fibrosis mutations. Trends Genet 1992;8: 392-8.
6. Zach MS. Lung disease in cystic fibrosis - an updated concept. Pediatr Pulmonol 1990;8:188-202.
7. Vasil ML. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology. J Pediatr 1986:108:800-5.
8. Corey M, Allison L, Prober C, Levison H. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital. J Infect Dis 1984;149: 283.
9. MacLusky IB, Levison H, Gold R, McLaughlin FJ. Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect? J Pediatr 1986;108:861-5.
10. Levy J. Antibiotic therapy in cystic fibrosis: evaluation of efficacy. Chest 1988;94(2 suppl)150S-3S.
11. Hoiby N. Antibiotic therapy for chronic infection of Pseudomonas in the lung. Annu Rev Med 1993;44:1-10.
12. Loening-Baucke VA, Mischler E, Myers MG. A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis. J Pediatr 1979;95:630-7.
13. Hoiby N, Pedersen SS, Jensen T, Valerius NH, Koch C. Fluoroquinolones in the treatment of cystic fibrosis. Drugs 1993;45(suppl 3): 98-101.
14. Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis. Am Rev Respir Dis 1985;132:761-5.
15. Wallace CS, Hall M, Kuhn RJ. Pharmacologic management of cystic fibrosis. Clin Pharm 1993;12:657-74.
16. Newman SP. Aerosol deposition considerations in inhalation therapy. Chest 1985:88(2 suppl):152S-60S.
17. Gerrity TR, Lee PS, Hass FJ, Marinelli A, Werner P, Lourenco RV. Calculated deposition of inhaled particles in the airway generations of normal subjects. J Appl Physiol 1979;47:867-73.
18. Swift DL. Generation and respiratory deposition of therapeutic aerosols. Am Rev Respir Dis 1980;122:71-7.
19. Pavia D, Thomson ML, Clark SW, Shannon HS. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax 1977;32:194-7.
20. Littlewood JM, Smye SW, Cunliffe H. Aerosol antibiotic treatment in cystic fibrosis. Arch Dis Child 1993;68:788-92.
21. Goldberg IS, Lourenco RV. Deposition of aerosols in pulmonary disease. Arch Intern Med 1973;131:88-91.
22. Mukhapadhyay S, Staddon GE, Eastman C, Palmer M, Davies ER, Carswell F. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir Med 1994;88:203-11.
23. Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis 1987;136: 1445-9.
24. Alderson PO, Seeker-Walker RH, Stominger DB. Pulmonary deposition of aerosols in children with cystic fibrosis. J Pediatr 1974;84:479-84.
25. Hardy JG, Newman SP, Knoch M. Lung deposition from four nebulizers. Respir Med 1993;87:461-5.
26. Weber A, Smith A, Williams-Warren J, Ramsey B, Covert DS. Nebulizer delivery of tobramycin to the lower respiratory tract. Pediatr Pulmonol 1994;17:331-9.
27. Stout SA, Derendorf H. Local treatment of respiratory infections with antibiotics. Drug Intell Clin Pharm 1987;21:322-9.
28. Cooney GF, Lum BL, Tomaselli M, Fiel SB. Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis. J Clin Pharmacol 1994;34:255-9.
29. Newman SP, Pellow PGD, Clarke SW. Choice of nebulizers and compressors for delivery of carbenicillin aerosol. Eur J Respir Dis 1986;69: 160-8.
30. Newman SP, Pellow PGD, Clay MM, Clarke SW. Evaluation of jet nebulizers for use with gentamicin solution. Thorax 1985;40:671-6.
31. Newman SP, Woodman G, Clarke SW. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax 1988;43:318-22.
32. Hung JCC, Hambleton G, Super M. Evaluation of two commercial jet nebulizers and three compressors for the nebulization of antibiotics. Arch Dis Child 1994;71:335-8.
33. Di Sant'Agnese PA, Anderson DA. Celiac syndrome. Am J Dis Child 1946;72:17-61.
34. Boxerbaum B, Pittman S, Doershuk CF, Stern RC, Matthews LW. Use of gentamicin in children with cystic fibrosis. J Infect Dis 1971;124 (suppl):S293-5.
35. Hoff GE, Schiotz PO, Paulsen J. Tobramycin treatment of Pseudomonas aeruginosa infections in cystic fibrosis. Scand J Infect Dis 1974;6:333-7.
36. Huang NN, Hiller EJ, Macri CM, Capitanio M, Cundy KR. Carbenicillin in patients with cystic fibrosis: clinical pharmacology and therapeutic evaluation. J Pediatr 1971;78:338-45.
37. Hodson ME. Antibiotic treatment: aerosol therapy. Chest 1988;94(2; suppl):156S-62S.
38. Smith AL. Antibiotic therapy in cystic fibrosis: evaluation of clinical trials. J Pediatr 1986;108:866-70.
39. Smith AL, Ramsey B. Aerosol administration of antibiotics. Pediatr Pulmonol 1995;11(suppl):68-9.
40. Fiel SB. Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis. Chest 1995;107(2; suppl):61S-4S.
41. Stephens D, Garey N, Isles A, Levison H, Gold R. Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis. Pediatr Infect Dis J 1983;3:209-11.
42. Schaad UB, Wedgewood, Krucko J, Suter S, Kraemer R. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr 1987;111:599-605.
43. Hodson ME, Penketh ARL, Batten JC. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet 1981;2:1137-9.
44. Kun P, Landau LI, Phelan PD. Nebulized gentamicin in children and adolescents with cystic fibrosis. Aust Paediatr J 1984;20:43-5.
45. Carswell F, Ward C, Cook DA, Speller DCE. A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis. Br J Dis Chest 1987; 81:356-60.
46. MacLusky IB, Gold R, Corey M, Levison H. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989;7:42-8.
47. Steinkamp G, Tummler B, Gappa M, Albus A, Potel J, Doring G, et al. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989;6:91-8.
48. Smith AL, Ramsey BW, Hedges DL, Hack B, Williams-Warren J, Weber A, et al. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol 1989;7:265-71.
49. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravilz RM, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993;328:1740-6.
50. Wall MA, Terry AB, Eisenberg J, McNamara M. Inhaled antibiotics in cystic fibrosis (letter). Lancet 1983;1:1325.
51. Wittenberg DF. Maintenance of Pseudomonas antibiotic sensitivity in patients with cystic fibrosis treated with inhaled antibiotics (letter). S Afr Med J 1987;77:335-6.
52. Littlewood JM, Miller MG, Ghoneim AT, Ramsden CH. Nebulized colomycin for early Pseudomonas colonization in cystic fibrosis (letter). Lancet 1985;1:865.
53. Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987;19: 831-8.
54. Valerius NH, Koch C, Hoiby N. Prevention of Pseudomonas aeruginosa colonization in cystic fibrosis by early treatment. Lancet 1991;338:725-6.
55. Nolan G, McIvor P, Levison H, Fleming PC, Corey M, Gold R. Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin. J Pediatr 1982;101:626-30.
56. Stead RJ, Hodson ME, Batten JC. Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa. Br J Dis Chest 1987;81:272-9.
57. Holzer FJ, Olinsky A, Phelan PD. Variability of airways hyperreactivity and allergy in cystic fibrosis. Arch Dis Child 1981;56:455-9.
58. Levy J, Smith AL, Kenny MA. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum. J Infect Dis 1983;148:1069-76.
59. Chrispin AR, Norman AP. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 1974;2:101-6.
60. Bosso JA, Liptak CA, Seilheimer DK, Harrison GM. Toxicity of colistin in cystic fibrosis patients. DICP Ann Pharmacother 1991;25:1168-70.
61. Bauldoff GS, Nunley DR, Manzetti JD, Williams P, Iacono AT, Dauber JH, et al. Use of aerosolized colistin in patients with cystic fibrosis awaiting lung transplantation (abstract). Pediatr Pulmonol 1995;12(suppl): 257-8.